Discussion board: pandemic patents | BUSI 561 – Legal Issues in Business | Liberty University

 

Thread:

The companies that developed the vaccines and treatments in the covid pandemic provide very real-life, real-time examples of the questions of protecting patents as business assets while answering social responsibility concerns.

As the CEO of one of these companies, how would you respond to calls to share your company’s IP and under what circumstances? How would a Biblical worldview influence your decisions?

Consider, for example, the following:

Rowland, C., Rauhala E., & Berger, M. (2021, March 20). Drug companies defend vaccine monopolies in face of global outcry. The Washington Post.

https://link.gale.com/apps/doc/A655745537/BIC?u=vic_liberty&sid=summon&xid=4321e4f8 (Links to an external site.)

D’Eminio, F. (2021, October 11). Moderna has no plans to share its COVID-19 vaccine recipe. AP. https://apnews.com/article/coronavirus-pandemic-technology-business-united-nations-europe-d4aff7ddb273194b312354a57c244ce6 (Links to an external site.)

Taylor, A. & Parker, C. (2021, October 27). U.S. drug company Merck to share license for experimental covid-19 treatment with nonprofit. Washington Post. https://bi-gale-com.ezproxy.liberty.edu/global/article/GALE%7CA680335867/3c02464fd736364ef628911fa70dea32?u=vic_liberty